BranchOut Food's Record Revenue, Broken Margins

BranchOut Food posts record revenue. It generated $97,000 of gross profit.

That $97,000 — the money left after paying for raw materials, labor, and production to make and deliver its dehydrated fruit and vegetable snacks — is what remains after the company brought in $4.46 million in Q2 2026 revenue. The result: a 2.2% gross margin, down from 17.8% a year earlier, even as revenue grew 36%.

A company that cannot profitably produce its own product has a growth story without an engine.

The numbers behind the headline

BranchOut Food (NASDAQ: BOF) built its public-market narrative around one idea: its GentleDry dehydration technology creates a proprietary snack platform that can scale across retail and industrial ingredient channels. The topline numbers in Q2 2026 looked like proof. Revenue hit $4.5 million — a quarterly record and 36% above the prior year. The company secured what it calls an $8 million annual program with the nation's second-largest warehouse club, plus five new product launches coming to a mass-market retailer in September. Management guided Q4 2026 revenue to $6–7 million and full-year 2026 toward $18–20 million.

But revenue is the easy number. It tells you how much product moved. It doesn't tell you whether moving it creates value.

Cost of goods sold grew 62% year over year to $4.36 million, far outpacing the 36% revenue increase. Gross profit shrank from $582,000 a year ago to $97,000. On an adjusted basis — removing stock-based compensation from COGS — the margin still collapsed from 24.3% to 8.3%. That's not a bad quarter; it's a broken economics quarter. Management attributed the deterioration to higher raw material costs and an unfavorable sales mix. Operating expenses grew their own separate story, rising to $2.66 million from $1.89 million. Salaries and wages climbed 55%. Advertising more than doubled. The net loss widened 70% to $2.72 million.

The balance sheet tells you why the market stopped caring about the growth headline. BranchOut held $211,985 in cash at the end of June. Total liabilities stood at $12.8 million, including $7.26 million in debt. The filing carries a going concern warning — management's own admission that existing cash and operating cash flows cannot cover requirements for at least the next 12 months. The company used $4.88 million of cash from operations in the first half of 2026 and has accumulated a $28.2 million deficit over its life.

The dilution that doesn't fix the math

The offering that set the current decline in motion was an at-the-market equity program launched January 27, 2026. Under this structure, BranchOut can sell shares directly into the market through agent Alexander Capital, raising up to $1.5 million over time. The company also filed a shelf registration in June 2026 covering 500,000 shares for resale by a selling stockholder. Together, these are financing mechanisms — not business milestones.

Here's what the dilution math looked like in the prospectus: as of late January 2026, BranchOut had approximately 13.4 million shares outstanding, a net tangible book value of $0.45 per share, and was trading at $2.84. Selling the full $1.5 million in shares at that price would add roughly 528,000 shares. Existing shareholders would see their book value rise by 9 cents. New investors buying at $2.84 would immediately own shares worth $2.30 less than they paid. The gap between price and book value is the dilution tax.

That was January. The fully diluted picture is worse. Beyond common shares, the company has roughly 4.48 million additional shares issuable upon conversion of $3.4 million in convertible notes, about 1.38 million from options, and 2.12 million from warrants. Each new issuance of common stock dilutes all of those claimants too.

The point is not that small companies need to raise capital — they do. The point is that equity financing does not cure unit economics. If each dollar of revenue costs 97.8 cents to produce, selling more shares doesn't make the 2.2% margin into a 17% margin. It just spreads the loss across more shareholders.

The argument in favor

Management's case rests on three claims, each of which requires patience and a tolerance for near-term pain:

Recurring programs will change the cost structure. The $8 million warehouse club deal moves from rotational testing to everyday placement across 309 clubs starting in September 2026. Management argues that continuous production — rather than batch runs for rotationals — drives manufacturing efficiency and lower unit costs. The additional $2 million Tropical Mix order reinforces demand.

Revenue scale unlocks operating leverage. The company expects to nearly double production capacity to 70–80 metric tons per month in the second half of 2026. At higher volumes, fixed costs spread across more units. The ingredient business alone is projected to exceed $10 million in revenue by 2027.

This is an investment period. CEO Eric Healy characterized Q2 as a phase where the company prioritizes winning large, repeat customer programs over short-term profitability. The logic is that customer concentration — four customers represented 95.9% of Q2 revenue, up from three customers at 99.1% a year ago — will normalize as the product base widens.

There's a Lake Street Capital buy rating from August 3 with a $6 price target to match this narrative. The thesis is that the warehouse club pipeline represents a step-function change in volume, and the margin collapse is temporary friction during ramp-up.

What needs to happen

The investment case requires margin recovery, and the timeline for that recovery is the single most important variable for this stock. Management's path depends on a specific sequence: the warehouse club deal converts from $8 million in estimated annual revenue to actual delivered volumes, production runs continuously instead of in batches, and the cost per kilogram drops below what it was a year ago when margins were 17.8%.

If that sequence works, the $6–7 million quarterly revenue target with restored margins would generate meaningful cash flow and make the accumulated losses a rear-view mirror. The company would validate that its technology and distribution are real, and the dilution from this period would become a historical footnote.

If it doesn't, the company faces a version of the problem that breaks most micro-cap growth stories: revenue keeps growing, cash keeps burning, and each new capital raise dilutes the existing holders without fixing the underlying economics. A company with $211K in cash and a going concern warning cannot wait out a slow ramp. It needs margin recovery to happen, and it needs it to happen while it still has credibility with customers and financiers.

The stock fell 12.1% in the two weeks after the Q2 report, trading from roughly $4.40 to the $3.85 range. A year ago at this point, it was trading near $5.25, its 52-week high. The price has moved down not because revenue failed to grow, but because the market stopped buying the premise that revenue growth without profitability is progress.

For an investor evaluating BranchOut Food, the question isn't whether the warehouse club deal is real — the evidence suggests it is — but whether a $4.5 million revenue quarter with a 2.2% gross margin and $211K in cash is the kind of business that recovers its margins, or the kind that keeps raising money until there's nothing left to raise.